HemaSphere
(Aug 2023)
P1016: RUSFERTIDE (PTG-300) IMPROVES POLYCYTHEMIA VERA (PV) RELATED SYMPTOMS IN PV PATIENTS
- Andrew Kuykendall,
- Marina Kremyanskaya,
- Yelena Ginzburg,
- Naveen Pemmaraju,
- Abdulraheem Yacoub,
- Frank Valone,
- Sarita Khanna,
- Suneel Gupta,
- Srdan Verstovsek,
- Ronald Hoffman
Affiliations
- Andrew Kuykendall
- 1 Moffitt Cancer Center, Tampa, United States
- Marina Kremyanskaya
- 2 Icahn School of Medicine at Mount Sinai, New York, United States
- Yelena Ginzburg
- 2 Icahn School of Medicine at Mount Sinai, New York, United States
- Naveen Pemmaraju
- 3 MD Anderson Cancer Center, Houston, United States
- Abdulraheem Yacoub
- 4 The University of Kansas Cancer Center, Fairway, United States
- Frank Valone
- 5 Protagonist Therapeutics, Inc, Newark, United States
- Sarita Khanna
- 5 Protagonist Therapeutics, Inc, Newark, United States
- Suneel Gupta
- 5 Protagonist Therapeutics, Inc, Newark, United States
- Srdan Verstovsek
- 3 MD Anderson Cancer Center, Houston, United States
- Ronald Hoffman
- 2 Icahn School of Medicine at Mount Sinai, New York, United States
- DOI
-
https://doi.org/10.1097/01.HS9.0000970968.04468.60
- Journal volume & issue
-
Vol. 7
p.
e0446860
WeChat QR code